BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Olimel Peri/Olimel®: Reduction of maximal infusion rate per hour in children

Active substance: emulsion for infusion for parenteral nutrition

The company Baxter Deutschland GmbH points out that the posology given in the Package Leaflets and Summaries of Product Characteristics of Olimel Peri/Olimel nutrient solutions is to be altered with regard to the maximal infusion rate of lipids per hour in children between the ages of 2 and 11 years, as the current statements are not in agreement with the recommendations of the 2005 ESPGHAN/ESPEN guidelines for this age group.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 552KB, File is accessible